PGEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Precigen Inc (PGEN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong growth potential driven by positive analyst ratings, increasing revenue, and promising product traction in the market. Despite some hedge fund selling, the overall outlook is favorable for long-term investment.
The stock's technical indicators are mixed. While the MACD is negative and expanding downward, indicating bearish momentum, the RSI is neutral at 47.155. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting an upward trend in the long term. Key support is at 3.844, and resistance is at 4.279, with the current pre-market price at 3.96, close to support levels.
Analysts have raised price targets to $9 and $10, citing strong early commercial traction for PAPZIMEOS and expected Q1 sales exceeding $18M.
Gross margin has significantly improved to 65.04%, showing operational efficiency.
Positive early launch metrics for PAPZIMEOS position it as a leader in its market.
Hedge funds have significantly increased selling activity (up 801.59% last quarter).
No recent news or congress trading data to provide additional confidence.
In Q4 2025, revenue surged by 283.61% YoY to $4.57M, and gross margin improved significantly to 65.04%. However, net income remains negative at -$23.5M, though it improved by 19.14% YoY. EPS remained flat at -0.07.
Analysts are optimistic, with price targets raised to $9 and $10 and Outperform/Buy ratings maintained. They highlight strong early sales metrics for PAPZIMEOS and its potential to dominate its market.
